Abstract
1,2,4-Triazole-containing scaffolds are unique heterocyclic compounds present in an array of pharmaceuticals and biologically important compounds used in the drug-discovery studies against cancer cells, microbes, and various types of disease in the human body. This review article summarizes the pharmacological significance of the 1,2,4-triazole-containing scaffolds and highlights the latest strategies for the synthesis of these privileged scaffolds using 3-amino-1,2,4-triazole. This review stimulates further research to find new and efficient methodologies for accessing new 1,2,4-triazole-containing scaffolds which would be very useful for the discover of new drug candidates.
Graphic abstract
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
It has been demonstrated that nitrogen-containing heterocycles have a significant effect on the process of discovering new structures for pharmaceutical applications. In addition, these compounds are extensively observed in nature and metabolic systems which are vital for living creatures [1,2,3]. Among the various nitrogen-containing heterocycles, 1,2,4-triazoles especially with unique structure and properties have usages in various fields such as pharmaceutic chemistry, agrochemistry, materials sciences, and organic catalysts. 1,2,4-Triazoles operate as main pharmacophores through hydrogen-bonding and dipole interactions with the biological receptors [4, 5]. The various 1,2,4-triazole products due to having N–C–S linkage in the skeleton have been introduced as an antimicrobial agent and various medicines such as Fluconazole, Flupoxam, and Anastrozole which containing 1,2,4-triazole group are common and well known [6, 7]. Among the different heterocyclic compounds, 1,2,4-triazoles attracted remarkable attention especially in the last two decades due to its widespread potential pharmaceutical activity including antibacterial, antifungal, anti-inflammatory, antioxidant, analgesic, and anticancer activities [8,9,10,11].
The biological importance of 1,2,4-triazole has led to the design of many methods for the synthesis of this scaffold that exhibits biological activity. Synthetic methods reported to date provide access to a wide range of 1,2,4-triazole via multistep synthetic routes [12,13,14,15,16]. In view of the increasing demand for the convenient and rapid synthesis of heterocycles with biological activities, surveys of the effective synthetic methods to products containing 1,2,4-triazole systems have increasingly raised in recent articles. The established previous methods demonstrate that multicomponent reactions (MCRs) are a direct and powerful process for the synthesis of different functionalized heterocyclic structures including triazoles [17,18,19]. Given the growing importance of 1,2,4-triazole in emerging sciences, it is necessary to provide a comprehensive review of this distinguished heterocyclic scaffold using 3-amino-1,2,4-triazole.
The Chemistry of triazole
One of the important heterocyclic products containing three nitrogen atoms in a five-membered ring is known as triazole with molecular formula C2H3N3 operates as isosteres of amide, ester and carboxylic acid. According to the position of the nitrogen atom in the five-membered ring, there are two possible isomers of triazole for instance, 1,2,3 and 1,2,4-triazoles (1 and 2) are numbered as illustrated in Fig. 1 [20, 21].
Triazole, also introduced as pyrrodiazole with a five-membered di-unsaturated ring skeleton consists of two carbon atoms and three nitrogen atoms at non-adjacent sites. Each of these has three tautomers (1a-c and 2a-c) which vary due to the fact that which nitrogen has hydrogen bonded that for 1,2,4-triazole, 1H-1,2,4-triazole (2a) is more stable than 4H-1,2,4-triazole (2b) as demonstrated in Fig. 2 [22].
Pharmacological significance of triazole scaffold
1,2,4-Triazole is one of the most significant scaffolds that can meet the needs of pharmaceutical chemistry and offers a variety of biological activities: for example, antihypertensive [23], anti-inflammatory [24], anticancer [25], antibiotic [26], anti-HIV [27], antioxidant [28], antileishmanial [29], and anticonvulsant [30]. This heterocyclic structure is the main component of a diverse kind of drugs available in clinical therapy, such as terconazole 3, itraconazole 4, fluconazole 5, bittertanol 6, cyproconazole (fungicides) 7, trazodone 8 (anti-depressant) and triazolam 9 (sedative and hypnotic), etc., represented in Fig. 3 which are frequently used in the pharmaceutical domain [4, 11, 31]. Triazole derivation is introduced according to the concept of bioisosterism, in which the oxygen exchange of the oxadiazole cores with the nitrogen atom happens and generates the triazole analogue. [21].
This wide range of biological and pharmaceutical properties has been facilitated by the synthetic diversity of triazole, which provides structural diversity and this has been surveyed by a number of synthetic researchers [32]. On the other hand, among other heterocyclic structures containing nitrogen, triazole derivatives were introduced as the most promising option for anti-tuberculosis properties [33].
The use of triazole-based drugs is the main method for the treatment of fungal diseases in both human and agriculture [34]. Triazole-based antifungals have been introduced as the third generation of antifungal drugs that have a broad range of antifungal properties in the treatment of a diversity of pathogenic fungi (Fig. 4) [5]. Also, triazole antifungal drugs are the first choice to treat infections due to Aspergillus Fumigatus [35].
In 2015, the group of Miceli and Kauffman defined the function of novel triazoles in the treatment of infections caused by invasive fungi. Isavuconazole 10 is a novel triazole with a wide range of therapeutic activity against dimorphic fungi, molds and yeasts. The use of this compound has also been verified as a therapeutic agent for mucormycosis and invasive aspergillosis (Fig. 5). The benefits of this triazole-based compound consist of the excellent bioavailability of the oral formulation, water-soluble formulation, availability, and expected pharmacokinetics in adults’ people [36].
Oral triazole efficiency is fully verified for the therapy of chronic (CPA), invasive (IPA), and allergic (ABPA) pulmonary aspergillosis that is often longtime. Microbiological recognition of aspergillosis is restricted by poor culture yield, result into indeterminacy about the frequency of triazole resistance. In 2011 Denning et al. found further indications for the stability of triazole for human antifungal treatment [37].
Although triazole derivatives are functional synthetic targets, some triazole-based drugs are not soluble in water and most other suitable medicinal solvents, so this leads to their negligible bioaccessibility and restricts their use in many drug release systems [38]. Some solubility modification attempts have been developed in recent years, including the use of microemulsion systems, polymer-based solid dispersions, and the formation of complex structures with crown ethers to increase the solubility of a triazole-based drug in water [39].
In order to solve this problem, in 2013 Kumar et al. prepared acid addition salts of itraconazole as a triazole-based antifungal agent to improve the water solubility and drug dissolution properties. Sulfuric, nitric, and p-toluenesulfonic acid addition salts were produced via straightforward preparation methods [40].
In 2010 Jubie et al. designed some new ciprofloxacin analogues 11 as antimicrobial agents (Fig. 6). Ciprofloxacin participates in the Mannich reaction to produce a novel class of 1,2,4-triazole Schiff bases. The novel products have been examined in vitro for their antimicrobial properties in order to eliminate B. subtilis, K. pneumoniae, and P. aeruginosa at 10 µg/ml concentration. Almost all the synthesized products demonstrated in vitro gram-positive and gram-negative properties that are generally analogous to ciprofloxacin or even better [41].
General procedures for the synthesis of 3-amino-1H-1,2,4-triazoles
Various methods have been reported for the formation of 3-amino-1H-1,2,4-triazoles 12, and most of these methods are based on the combinatorial synthesis, solid-phase reaction, and using microwave [42]. Some of these methods are described below. The first procedure, proposed by Bozo, including a two-step mechanism: first opening of 1,3,4-oxadiazolium perchlorate motifs 13 by the nucleophile cyanamide and subsequent recyclization (Scheme 1) [43].
The second procedure, introduced by Meng is based on a robust, regioselective method for the formation of 3-amino-1,2,4-triazoles 12. This method used a basic intermediate 15, which is reacted with carboxylic acids in good efficiency to proposed intermediates 16. In the following, these intermediates, interact with a diversity of hydrazines or hydrazine hydrochlorides to generate offered intermediates 17, which using microwave-assisted heating under controlled conditions to produce 3-amino-1,2,4-triazoles 12 (Scheme 2). This method provided the rapid synthesis of regioselective N1-substituted 3-amino-1,2,4-triazoles and obtained different products with structural diversity.
The third procedure was recently described by Bogolyubsky and coworkers, presenting an interesting one-pot synthetic procedure for the fast formation of a class of 3-amino-1,2,4-triazoles 12 with structural diversity of products. In the main steps, the formed thioureas undergoes S-alkylation with 1,3-propane sultone and subsequential ring closure led to the synthesis of expected 1,2,4-triazoles (Scheme 3). Parallel synthesis generates many 1,2,4-triazoles with structural diversity in a cost- and time-effective process from simple and commercially available materials [45].
The next synthesis method includes the development of a straightforward and suitable new methodology for the formation of 3-amino-1,2,4-triazoles 12 that illustrated in Scheme 4. This process includes a one-pot reaction of aminonitrile 18 with various alkyl and aryl nitriles that catalyzed with iron (III) chloride. Trimethylphosphine is applied as a ligand without the use of any further additive. This one-pot reaction takes place under mild conditions for the synthesis of various types of aryl-3-amino-1,2,4-triazoles with excellent efficiencies. This new procedure is highly sustainable in comparison with previously reported methodologies. Rohand and coworkers' research team suggested that these processes could be used to synthesize the 3-amino-1,2,4-triazole required for new drug synthesis [46].
Strategies for synthesis of triazole-containing scaffolds using of 3-amino-1,2,4-triazole
One of the suitable procedures to produce nitrogen-containing heterocycles is the use of 3-amino-1,2,4-triazole 12 as an effective mono-, bi- and polynucleophile with different electrophiles in two, three or multi-component and one-pot reaction. 3-Amino-1,2,4-triazoles 12 are beneficial reagents in controlled multidirectional reactions because they have multiple alternative reaction centers, makes it possible to synthesize a variety of chemical types of heterocyclic products (some examples in Fig. 7) [47].
Multicomponent reactions (MCRs) containing 3-amino-1,2,4-triazoles 12 and aldehydes with diverse CH-acids are analogous to the classic Hantzsch or Biginelly condensation reactions. In previous literature these reactions had mostly led to the generation of mixtures of positional and regioisomers, accordingly, several effective procedures were found and developed for adjustment chemo- and regioselectivity of these reactions which heterocycle formed via cyclization, containing strategies for changing reaction conditions such as temperature, type of solvent and type of energy source required for activation; microwave irradiation (MW) and ultra-sonication (US), type of catalyst and, etc., for switching their directions of heterocyclization [47].
In 2012, Sedash and coworkers published a review article that completely justified the structural diversity and complexity of the MCRs of 3-amino-1,2,4-triazoles 12 as 1,3-binucleophiles with carbonyl compounds and non-cyclic CH-acids on the Biginelly-type reaction. It was displayed that the step-by-step properties of the MCRs and the existence of various nucleophilic sites on the 3-amino-1,2,4-triazoles 12 could result in at least eight plausible structural diverse compounds A–H from the similar precursors. Reaction conditions and also the type of precursors' structure determine which of these products can be the major product. The pairs A–B, C–D, E–F, and G–F could be demonstrated as positional isomers while the pairs A–C, B–D, E–G, and F–H as regioisomers. Due to such a possible structural variety in obtained products, it is most difficult to determine the structure of the final product (Fig. 8).
They studied the literature related to these kind of reactions and found that the available information about the structure of the products A–H obtained from these reactions was not always reliable and concluded that structure A as the most usual product in most articles which described Biginelli-like MCRs containing 3-amino-1,2,4-triazoles 12 using really harsh conditions and various precursors. The product C is sometimes created as a by-product along with the generation of the major product A. Only the reaction of 3-amino-1,2,4-triazoles 12 with acetylpyrazole precursor led to the synthesis of compound C as the sole product. Synthesis of tetrahydro derivatives F were reported in the reactions with phenyl pyruvic acid or ethyl acetoacetate in mild conditions. The product E could be acquired in kinetic conditions from the reaction of fluorinated esters of acetoacetic acid and further converted to type A heterocycles in thermodynamically controlled conditions. Products with structure B could only be obtained if two molecules of acetophenone or cyclohexanone involved with 3-amino-1,2,4-triazole 12. The compound D is synthesized by methods other than the Biginelli-like MCRs method, and also, the synthesis of products with G and H structure has not been reported so far. The facts about the dominant product formation with structure A in the multicomponent reactions containing 3-amino-1,2,4-triazole that suggested by Sedash et al. were verified by the other subsequent literature [48].
This section presents research into the expansion of new methods for the formation of triazole-containing scaffolds using 3-amino-1,2,4-triazole 12 in multi-component reactions as follows:
In 2005 Chebanov et al. developed three-component reaction of aromatic aldehydes with pyruvic acid 19 and 3-amino-1,2,4-triazole 12 as starting materials for the formation of 5-aryl-5,8-dihydroazolo[1,5-a]pyrimidine-7-carboxylic acids 20 in glacial AcOH. They realized that refluxing of pyruvic acid with aldehydes and 3-amino-1,2,4-triazole in DMF results in the synthesize of two isomers 20 and 21 (Scheme 5). The structure of the obtained products depends on the type of solvent used in the reaction [49].
Later Parchinsky and co-workers examined the three-component condensation between aromatic aldehydes, isonitriles 22, and 3-amino-1,2,4-triazole 12 in order to conveniently synthesize structural diversity ranges of imidazo[1,2-b][1,2,4]triazoles 23. They found when benzylic isonitriles are used; the obtained heterocyclic products can be produced in an oxidized form in moderate to good yields. Oxidation process happened at the benzylic moiety to synthesize N-alkylidene-4H-imidazo[1,2-b][1,2,4]triazol-6-amines 24 that confirmed the unusual resistance to reduction and acid hydrolysis (Scheme 6). It is thought that the attendance of a readily oxidized benzyl moiety in final structures is a prerequisite for the success of Groebke-type MCR of 3-amino-1,2,4-triazole [50].
In 2008 Sakhno and coworkers studied the multicomponent condensation of 3-amino-1,2,4-triazoles/5-aminotetrazole with phenyl pyruvic acids 25 and aromatic aldehydes in different conditions including, ultrasonication, microwave-assisted heating, and thermal heating. In kinetic or thermodynamic control conditions, the type of obtained product and the reaction pathways for cyclocondensations depend on the reaction temperature and the type of precursors. In the case of amino triazole, they realized that an unprecedented reaction route resulted in the synthesize of 5-aryl-7-hydroxy-6-phenyl-4,5,6,7-tetrahydro[1,2,4]triazolo[1,5-a]pyrimidine-7-carboxylic acids.
The outcomes reported above verify their supposition about thermodynamic and kinetic control in the reactions illustrated in Scheme 7 and therefore provide an easy adjusting of chemoselectivity through alteration of the medium temperature. The kinetic triazolopyrimidine derivatives 26 obtained when the precursors undergo sonication for 30 min at ambient temperature or heating at 120 °C in acetic acid solvent for 2 min, while pyrrolones 27 obtained as thermodynamically control products in microwave-assisted conditions at 150 °C for 180 min or refluxing conditions at 120 °C for 180 min. Furthermore, it was confirmed when the reaction of Schiff bases 28 and phenyl pyruvic acid 25 irradiated with sonication source in HOAc solvent and ambient temperature for 30 min or heated with a thermal source for 2–5 min also provided triazolopyrimidines 26 as selective product (Scheme 8) [51].
In 2009 Chen and coworkers studied the three-component reaction of 3-amino-5-alkylthio-1,2,4-triazoles 12 with β-ketoester 29 and aromatic aldehydes to introduce a Biginelli-analogous reaction with the regioselective manner for the synthesize of 30 and 31 (Scheme 9). The results demonstrated that the solvent type of reaction and the structure of the β-ketoester material showed a significant effect on the regioselectivity. This reaction, for the first time, shows the regioselectivity of a Biginelli reaction that uses aminotriazole as one of the starting materials [52].
In 2009 Lipson et al. found the reaction of 3-amino-1,2,4-triazoles 12 with cinnamaldehyde 32 proceeds through two directions and resulted in 5-[N-(3-phenylpropenylideneamino)]-1H-1,2,4-triazoles 33 and 5-phenyl-4,5,6,7-tetrahydro[1,2,4]triazolo[1,5-a]pyrimidin-7-ols 34 (Scheme 10) [53].
In 2010 Gorobets et al. understood that using 3-amino-1,2,4-triazole in Biginelli-like three-component condensation led to synthesis of tetrahydro pyrimidone ring via an unexpected alternative direction. They concluded that the 3-amino-1,2,4-triazole operates in a different way in comparison to other aminoazoles in the Biginelli-analogous multi-component condensation. The aldehyde precursor interacted with the exocyclic amino group of the 3-amino-1,2,4-triazole 12 instead of the endocyclic nitrogen of the triazole ring and results in the product 35. The conventional and microwave heating were identified as optimized reaction conditions using salicylic aldehydes as a model reaction. Also, in order to form the related oxygen-bridged compounds 36, they developed an efficient microwave-assisted procedure (Scheme 11) [54].
In 2011 Rudenko et al. reported the reaction of N-arylmaleimides 37 with 3-amino-1,2,4-triazole 12 in various solvents including dioxane in heating condition, in n-pentanol, acetic acid and ethanol and also without solvent by melting together by 150–160 °C that compounds 38 and 39 were obtained (Scheme 12). It has been confirmed that performing the reaction under dioxane or isopropanol solvent conditions results in the regioselective generation of product 38. product 39 can be prepared selectively by heating 37 and 12 in acetic acid solvent for not more than 1 h; performing this reaction under these conditions for a longtime results in mixture of products 38 and 39 [55].
In 2012 Gladkov and coworkers investigated two kinds of heterocyclization reactions between 4-amino-5-carboxamido-1,2,3-triazole 40 and cyclic ketones 41 under normal thermal heating, using the microwave as well as ultrasonic irradiation. ABB′-type MCR carrying out with chemo-differentiation of cyclopentanone or cyclohexanone precursors and obtains 4,5,6,7-tetrahydrospiro{cyclopenta[d][1,2,3]triazolo[1,5-a]pyrimidine-8,1′-cyclopentane}-3-carboxamide 42a or 5,6,7,8-tetrahydro-4H-spiro{[1,2,3]triazolo[5,1-b]quinazoline-9,1′-cyclohexane}-3-carboxamide 42b in all tested conditions (Scheme 13). The use of methanol as solvent with microwave irradiation conditions at 120 °C were reported as optimal conditions [56].
Another example of the direct relationship between reaction path and applied conditions reported in the paper published by Muravyova et al. (2011) and illustrated in Scheme 14. By changing the temperature of the reaction system and using ultrasonic, the direction of reaction including aromatic aldehydes, acetoacetamides 43, and substituted 3-amino-1,2,4-triazole 12 switches between kinetically and thermodynamically controlled paths and selectively generate tetrahydro- or dihydro derivatives 44 or 45, respectively (Scheme 14) [57].
In 2011 Kolos et al. found that cyclocondensation of esters 46 was also done with the 3-aminotriazole 12. It has already been explained that the synthesis of [1, 2, 4]triazolo[1,5-a]pyrimidine compounds using α,β-unsaturated ketones, and amine 12 requires really harsh conditions, including using of DMF or butanol as solvent under reflux condition. Because the reaction of esters 46 and amine 12 in DMF under reflux conditions resulted in the tarring of products, so they used of ethanol and reflux conditions that led to the formation of the triazolo[1,5-a]pyrimidines 47 with good efficiencies (Scheme 15) [58]. Optimization of the ester functional group was performed by the involving of compounds 47 with hydrazine hydrate. But, reported in the literature that 6-arylpyridazin-3(2H)-ones acquired as products of this reaction instead of the expected hydrazides.
To improve the triazolopyrimidine classes to clinical application, it was essential to recognize and synthesize an optimized product that exhibits both ability and good pharmacokinetic characteristics. The application of 1,3-dielectrophiles in the azoloazine formation is not restricted to the enones. For example, in 2011 Gujjar and coworkers used β-dicarbonyl compounds, such as substituted ethyl acetoacetate 48 for the synthesis of the pyrimidine core with substituents in C4 and C6 of 49a-c (Scheme 16). The asymmetric β-dicarbonyl precursors can provide positional isomers, while most processes show only one of the isomers. The aminoazoles-containing pyrrole N-atom in the α-position relative to the NH2-group are often applied as 1,3-binucleophiles [59].
In 2011 Saito et al. replaced easily acetoacetic esters using sodium nitromalonaldehyde monohydrate or malonic ester. The malonic ester 50 was applied as impressive precursor for the formation of the azoloazines 51 with substitute in the C5 (Scheme 17) [60].
In 2013 Petrova and coworkers reported a new three-component condensation between cyclic 1,3-diketones, 3-aminotriazole 12, and glyoxal for the formation of a new series of indolo[1,2-c]azolo[1,5-a]quinazoline-8,10-diones. In these MCRs, if glyoxales and arylglyoxales 52 are used instead of aldehyde, the reaction can proceed via a variety of routes. Therefore, Petrova and coworkers examined the reactions of a broad range of aminoazoles with glyoxales 52 and 1,3-diketones under refluxing condition in ethanol solvent and the new heterocyclic compounds indolo[1,2-c]polycyclic compounds 53 were obtained (Scheme 18) instead of expected 4,5,6,7,8,9-hexahydro-8-oxoazolo[5,1-b]quinazoline-9-carbaldehyde products [61].
In 2014 Niu and coworkers developed a new method for the synthesis of tricyclic systems named 1,2,4-triazoloquinoxalines 55 via a transition metal-free tandem method and in a one-pot condensation/nucleophilic aromatic substitution process. This protocol used to a wide spectrum of precursors such as 2-halogenated or 2-nitro aryl aldehydes and ketones 54 (Scheme 19). In addition to aldehydes, ketones also react well, resulting in tricyclic products [62].
In 2015 A Farghaly and coworkers introduced a method for the formation of pyrido[4,3-d]triazolo[1′,5′-a]pyrimidines 57 7 via in situ oxidized triazolopyrimidine process, using 1-ethyl-4-piperidinone 56 as a cyclic ketone in the condensation with two equivalents of aromatic aldehyde and 3-amino-1,2,4-triazole 12 with convenient thermal heating (acetonitrile-I2, 10% mol, 100 °C) (Scheme 20) [63].
In 2015 Shaabani et al. described a green multi-component procedure for the formation [1, 2, 4]triazolo[1,5-a]pyrimidine-6-carboxamides 60 using a one-pot reaction involving an aldehyde, 3-amino-1,2,4-triazole 12, a primary aliphatic or aromatic amines 58, and 2,2,6-trimethyl-4H-1,3-dioxin-4-one 59 (Scheme 21). The first step is performed in solvent-free conditions and heating at 150 °C for 30 min, then the second step is followed using a catalytic amount of p-toluene sulfonic acid in water for 4–6 h [64].
In 2015 Karami et al. developed a novel, environmentally friendly formation of 5,9-dihydropyrimido[5,4-e][1,2,4]triazolo[1,5-a]pyrimidine-6,8(4H,7H)-diones 62 by using a one-pot condensation of 1,3-dimethylbarbituric acid 61, 3-amino-1H-1,2,4-triazoles 12, and aromatic aldehydes (Scheme 22). The reactions follow the principles of green chemistry without using any catalysts or solvents throughout the processes.
An acceptable mechanism for the synthesis of derivatives 62 is illustrated in Scheme 23. It is plausible that arylidene-1,3-dimethyl barbituric acid 63 is formed via Knoevenagel condensation between 1,3-dimethyl barbituric acid 61 and aldehyde. Then 3-amino-1H-1,2,4-triazole 12 can be attacked to intermediate 63 to generate intermediate 64, which transformed into 65 via an N-cyclization, in following, dehydration leads to generate the expected compound [65].
In 2015 Murlykina et al. developed techniques for determination of the selectivity of MCRs containing 3-amino-1,2,4-triazole 12 and pyruvic acids 19. The route of the reaction depends on the temperature and structures of the starting materials, so it is possible to switch between alternative pathways and synthesize several structural varieties of products.
Accordingly, the product 66 named 7-hydroxy-5-aryl-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidine-7-carboxylic acids obtained from three-component condensation of 3-amino-1,2,4-triazole 98 and pyruvic acid 99 with salicylic aldehydes and anisaldehydes in mild heating condition. But when reaction carried out in reflux condition or microwave irradiation, the condensation of the similar precursors provides 7-aryl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acids with a free carboxylic group 67, that could potentially create complexes with various metals (Scheme 24). When they used arylpyruvic acids 25, the reaction in sonication condition results in compounds analogous to products synthesized with pyruvic acid, i.e., 7-hydroxy-5,6-diaryl-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidine-7-carboxylic acids 68. But using heating to reflux temperature or microwave irradiation condition, the similar precursors results in 3-hydroxy-4,5-diaryl-1-(1H-1,2,4-triazol-5-yl)-1H-pyrrol-2(5H)-ones 69 (Scheme 25) [66].
In 2015 Aouali and coworkers reported a rapid and effective microwave-assisted procedure for the formation of a spectrum of fused imidazo-5-amino-1-phenyl-1,2,4-triazoles 70 in good to excellent efficiencies through Groebke–Blackburn–Bienaymé three-component reaction (GBB-3CR) with involving of 3-amino-1,2,4-triazoles 12, aromatic or aliphatic aldehydes and substituted isocyanides (Scheme 26). This protocol should be effective for the formation of classes of these products with modified yield and high-throughput synthetic procedures. In GBB-3CR and sometimes in Ugi-4CR, Brønsted or Lewis acids are mostly applied to activate intermediate imine. In this GBB-3CR, in order to optimize the reaction conditions, almost all types of solvents such as water and ionic liquids, different catalysts, and different temperature treatments (thermal heating or microwave irradiation) were examined.
A plausible mechanism for this scandium triflate triggered Groebke–Bienayme´–Blackburn reaction is illustrated in Scheme 27. In this case, the reaction of the amine group with aromatic aldehyde provides an intermediate imine. The use of a broad range of aromatic aldehydes provides structurally diverse iminium intermediates. The trapping of these more electrophilic iminium intermediates using the isocyanide produced imidazo[2,1-c][1,2,4]triazoles 70 in middle efficiency [67].
In 2015 Karami and coworkers described a novel method involving a one-pot reaction of 3-amino-1H-1,2,4-triazole 12, dimethyl acetylenedicarboxylate (DMAD) 71, and aryl aldehydes applying silica sodium carbonate (SSC) as a solid base catalyst for the synthesis of dimethyl 4,5-dihydro-5-aryl-[1,2,4]triazolo[1,5-a]pyrimidine-6,7-dicarboxylates 72 (Scheme 28). Using of heterogeneous solid base (SSC), provides the possibility of the separation of dimethyl 4,5-dihydrotriazolopyrimidine-6,7-dicarboxylates 72 in this reaction. The authors proposed that the use of base assist the synthesis of an intermediate due to reaction between NH group in C2 of 3-amino-1,2,4-triazole 12 and active carbon of dimethyl acetylenedicarboxylate 71 that in the continuation of the reaction, the involving of aldehyde, cyclization and dehydration process occurs.
A rational mechanism for the formation of product 72 is illustrated in Scheme 29. At first step, intermediate 73 is formed through the reaction of 3-amino-1H-1,2,4-triazole 98 and DMAD 71 using SSC. In the following, intermediate 73 attacks the aldehyde to generate intermediate 74. Eventually, heterocyclization and dehydration processes occurred on intermediate 75 led to formation 152 [68].
In 2017 Moustafa and coworkers found an impressive and green method for the formation of novel classes of nitrogen bridgehead [1, 2, 4]triazolo[5,1-c][1,2,4]triazepine derivatives 77 via one-pot three-component condensation of polyfunctional triazole 76 with aromatic aldehydes and acetophenone in alcoholic sodium hydroxide solution (Scheme 30) [69].
In 2017 Komykhov and coworkers developed a three-component reaction of 1H-1,2,4-triazol-3-amine 12, aromatic aldehydes and acetone in the presence of TsOH as a Brønsted–Lowry acid for the synthesis of (5S,7R)-5-Aryl-7-methyl-4,5,6,7-tetrahydro[1,2,4]triazolo[1,5-a]pyrimidin-7-ols 78 (Scheme 31). They studied the antimicrobial and antifungal properties of these novel compounds in vitro tests [70].
In 2017 Miszczyk and coworkers investigated the reaction of 3-amino-1,2,4-triazole, triethyl orthoformate and diethyl phosphite led to the synthesis of the anticipated 1,2,4-triazoly-3-ylaminomethylenebisphosphonic acid 79; although, in this reaction, remarkable quantities of N-ethylated products (80–83) was synthesized which these structures verified by isolation (Scheme 32). Acid–base characteristics of both obtained products 79 and 80 were specified applying potentiometry, UV and NMR titrations. Although there is a potential for substitution of the ethyl functional group in the 1,2,4-triazole scaffold, it was confirmed that product 80 similar to compound 79, contained an acidic CH on the triazole scaffold that be able to create H-bonding [71].
In 2018 Gladkov et al. prepared a new spiro derivative of dihydro-1,2,3-triazolo[1,5-a]pyrimidine 84 by three-component condensation of 3-amino-1,2,4-triazole 12 and various amines with malononitrile and cyclohexanone (Scheme 33). The activation of precursors by microwave irradiation and thermal heating led to the synthesis of a single product that follows a similar heterocyclization pathway [72].
In 2018 El-Saghier et al. synthesized novel 3-(2-hydroxyphenyl)-3H-imidazo[2,1-c][1,2,4]triazol-6(5H)-one 86, 87, 88 and 3-N-arly(alkyl) amino acid connected triazoles 89, 90 as potential antileishmanial agents using from 3-amino-5-(2-hydroxyphenyl) amino acid connected triazoles 85 as starting substance (Scheme 34) [73].
A more effective multi-component one-pot procedure for the formation of imidazo[2,1-c][1,2,4]triazole-5-amine products 92 has been reported based on the reaction of easily accessible aromatic aldehydes, benzoyl cyanide 91 and 3-amino-1,2,4-triazole 12 in pyridine undergo controlled microwave irradiation condition (Scheme 35). This protocol has some advantages including; environmentally friendly, simple operation, short reaction time and excellent efficiencies [74].
In the view of above-mentioned points about the biological importance of triazole containing scaffolds, in 2020 Safari and coworkers described an interesting one-pot three-component condensation for the formation of novel triazolo pyrimidine compounds introduced as N-methyl-6-nitro-5-phenyl-[1,2,4]triazolo[1,5-a]pyrimidine-7-amine 95 using condensation of 3-amino-1,2,4-triazole 12, aliphatic or aromatic aldehydes 93 or 93′ and N-methyl-1-(methylthio)-2-nitroethenamine 94 using trichloroacetic acid (TCAA) as a Brønsted–Lowry acidic catalyst in acetonitrile (for aryl aldehydes) or water (for heterocyclic aldehyde) as reaction solvent and at ambient temperature (Scheme 36). In the case of using heteroaromatic aldehydes, this method usually results in oxidized [1, 2, 4]triazolo[1,5-a]pyrimidine 96, but in other cases where aromatic aldehydes were used, the last dehydration process did not occur and the reaction stopped on the synthesis of the corresponding dihydro[1,2,4]triazolo[1,5-a]pyrimidine 95. The attendance of five nitrogen heteroatoms in these products leads to an increase in the potential of biological values that has attracted considerable attention of chemists and biologists [75].
A rational mechanism for the synthesis of compound 95 is illustrated in Scheme 37. At the first step, the reaction of 3-amino-1,2,4-triazole and aldehyde in the presence of TCAA led to form an imine (Schiff base) 97. The important point is that aldehyde precursor condensed with the 3-amino-1,2,4-triazole 12 via the exocyclic amino group not the endocyclic nitrogen of the triazole moiety. In the following, the reaction of N-Methyl-1-(methylthio)-2-nitroethenamine 94 as an enamine type with intermediate 97 carried out through an aza-ene addition continues by imine–enamine tautomerism to produce open-chain intermediate 98. Then two processes including N-heterocyclization and the removal of thiol occur on intermediate 99 and the product 98 is generated. Finally, the proton transfer of intermediate 99 led to final compound 95. In the case of the formation of compound 96, the generation of these heterocycles can be justified using the oxidation process through the air stream. Indeed, the resonance of the new double bond with low-electron-ring of pyridine leads to the stabilization of product 96, therefore product 96 tends to oxidize and generate a double bond [75].
Conclusions
1,2,4-Triazole is a significant nitrogen-based heterocycle in the organic chemistry and pharmaceutical field because of its biological activities, potential therapeutic applications and chemotherapeutical values. In this review, we have highlighted some recent synthetic approaches for the synthesis of versatile 1,2,4-triazole heterocycles using 3-amino-1,2,4-triazole. 3-Amino-1,2,4-triazole is an effective mono- or bi-nucleophile in controlled multidirectional reactions that lead to the synthesis of a variety of heterocycles with a high number of heteroatoms. Overall, we hope that this review will assist the chemists in choosing the appropriate methodology for the formation of 1,2,4-triazole based scaffolds and motivate the creation of new synthetic methods in this field.
References
Arora P, Arora V, Lamba HS, Wadhwa D (2012) Importance of heterocyclic chemistry: a review. Int J Pharm Sci Res 3:2947–2954
Xue W, Warshawsky D (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73–93
Shaikh AR, Farooqui M, Satpute RH, Abed S (2018) Overview on nitrogen containing compounds and their assessment based on ‘International Regulatory Standards.’ J Drug Delivery Ther 8:424–428
Aggarwal R, Sumran G (2020) An insight on medicinal attributes of 1,2,4-triazoles. Eur J Med Chem 112652.
Peyton LR, Gallagher S, Hashemzadeh M (2015) Triazole antifungals: a review. Drugs Today 51:705–718
Gopalrao Rajurkar V, Shirsath M, S, (2017) Green synthesis and evaluation of 5-(4-aminophenyl)-4-aryl-4H-1,2,4-triazole-3-thiol derivatives. Iran J Pharm Sci 13:37–50
Rao DN, Prasad ARG, Spoorthy YN, Rao DR, Ravindranath LK (2014) Synthesis, characterization and pharmacological studies of sulphur containing 1,2,4-triazole derivatives. J Taibah Univ Sci 9:293–300
El Sayed H, Esam ER, Rezki N, Abou-Elnaga HH, Bakry WM, Boghdadi YM (2014) Evaluation of some functionalized imidazoles and 1,2,4-triazoles as antioxidant additives for industrial lubricating oils and correlating the results with the structures of additives using empirical AM1 calculations. J Saudi Chem Soc 18:443–449
Bhanojirao ME, Rajurkar VG (2009) Synthesis and biological evaluation of 5-pyridine-4-(arylidine amino)-3-mercapto-4(H)-1,2,4-triazoles. Asian J Chem 21:4733–4736
CEYLAN, Ş, (2016) Synthesis and antimicrobial activities of new 1,2,4-triazoles, Mannich bases, conazoles, and fluoroquinolones. J Turk Chem Soc, Sect A 3:747–764
Vanjare BD, Mahajan PG, Dige NC, Raza H, Hassan M, Han Y, Lee KH (2020) Novel 1,2,4-triazole analogues as mushroom tyrosinase inhibitors: synthesis, kinetic mechanism, cytotoxicity and computational studies. Mol Diversity, in press.
Al-Masoudi IA, Al-Soud YA, Al-Salihi NJ, Al-Masoudi NA (2006) 1,2,4-Triazoles: Synthetic approaches and pharmacological importance. Chem Heterocycl Compd 42:1377–1403
Moulin A, Bibian M, Blayo AL, El Habnouni S, Martinez J, Fehrentz JA (2010) Synthesis of 3,4,5-Trisubstituted-1,2,4-triazoles. Chem Rev 110:1809–1827
Hitotsuyanagi Y, Motegi S, Fukaya H, Takeya K (2002) A cis amide bond surrogate incorporating 1,2,4-triazole. J Org Chem 67:3266–3271
Blayo AL, Brunel F, Martinez J, Fehrentz JA (2011) Synthesis of various chiral 1,2,4-triazole-containing α-amino acids from aspartic or glutamic acids. Eur J Org Chem 2011:4293–4297
Banerjee S, Ganguly S, Sen KK, India BWB (2013) A review on 1,2,4-triazoles. J Adv Pharm Educ Res 3:102–115
Tam A, Armstrong IS, La Cruz TE (2013) Multicomponent synthesis of 1-aryl 1,2,4-triazoles. Org Lett 15:3586–3589
Yang N, Yuan G (2018) A multicomponent electrosynthesis of 1,5-disubstituted and 1-aryl 1,2,4-triazoles. J Org Chem 83:11963–11969
Amer AA, Moustafa AH (2016) Synthesis of 3-pyrazolyl-1,2,4-triazoles via one-pot multicomponent reaction in phosphoric acid. Synlett 27:1703–1706
Cox JR, Woodcock S, Hillier IH, Vincent MA (1990) Tautomerism of 1,2,3-and 1,2,4-triazole in the gas phase and in aqueous solution: a combined ab initio quantum mechanics and free energy perturbation study. J Phys Chem 94:5499–5501
Sharma V, Shrivastava B, Bhatia R, Bachwani M, Khandelwal R, Ameta J (2011) Exploring potential of 1,2,4-triazole: a brief review. Pharmacol 1:1192–1222
Keri RS, Patil SA, Budagumpi S, Nagaraja BM (2015) Triazole: a promising antitubercular agent. Chem Biol Drug Des 86:410–423
Ali KA, Ragab EA, Farghaly TA, Abdalla MM (2011) Synthesis of new functionalized 3- substituted [1,2,4]triazolo[4,3-a]pyrimidine derivatives: Potential antihypertensive agents. Acta Pol Pharm 68:237–247
Palaska E, Şahin G, Kelicen P, Durlu NT, Altinok G (2002) Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 57:101–107
Holla BS, Veerendra B, Shivananda MK, Poojary B (2003) Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur J Med Chem 38:759–767
Eswaran S, Adhikari AV, Shetty NS (2009) Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. Eur J Med Chem 44:4637–4647
Küçükgüzel I, Tatar E, Küçükgüzel ŞG, Rollas S, De Clercq E (2008) Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy) methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents. Eur J Med Chem 43:381–392
Pokuri S, Singla K, R, G Bhat V, G Shenoy G, (2014) Insights on the antioxidant potential of 1,2,4-triazoles: synthesis, screening & QSAR studies. Curr Drug Metab 15:389–397
El-Saghier AM, Mohamed MA, Abd-Allah OA, Kadry AM, Ibrahim TM, Bekhit AA (2019) Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles. Med Chem Res 28:169–181
Kaproń B, Czarnomysy R, Wysokiński M, Andrys R, Musilek K, Angeli A, Plech T (2020) 1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy. J Enzyme Inhib Med Chem 35:993–1002
Zhou H, C, Wang Y, (2012) Recent researches in triazole compounds as medicinal drugs. Curr Med Chem 19:239–280
Sathish Kumar S, Kavitha P, H, (2013) Synthesis and biological applications of triazole derivatives–a review. Mini-Rev Org Chem 10:40–65
Patel NB, Khan IH, Rajani SD (2010) Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles. Eur J Med Chem 45:4293–4299
Bowyer P, Denning DW (2014) Environmental fungicides and triazole resistance in Aspergillus. Pest Manage Sci 70:173–178
Dunne K, Hagen F, Pomeroy N, Meis JF, Rogers TR (2017) Intercountry transfer of triazole-resistant Aspergillus fumigatus on plant bulbs. Clin Infect Dis 65:147–149
Miceli MH, Kauffman CA (2015) Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis 61:1558–1565
Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Perlin DS (2011) High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 52:1123–1129
Heeres J, Meerpoel L, Lewi P (2010) Conazoles Molecules 15:4129–4188
DiNunzio JC, Brough C, Miller DA, Williams RO III, McGinity JW (2010) Fusion processing of itraconazole solid dispersions by KinetiSol® dispersing: a comparative study to hot melt extrusion. J Pharm Sci 99:1239–1253
Kumar N, Kapoor VR (2013) Facile syntheses of novel salts of a triazole antifungal agent with enhanced solubility. J Heterocycl Chem 50:490–495
Jubie S, Sikdar P, Kalirajan R, Gowramma B, Gomaathy S, Sankar S, Elanga K (2010) Synthesis and antimicrobial activity of some novel ciprofloxacin analogues. J Pharma Res 3:511–513
Maddila S, Pagadala R, Jonnalagadda B, S, (2013) 1,2,4-Triazoles: A review of synthetic approaches and the biological activity. Lett Org Chem 10:693–714
Bozo E, Szilágyi G, Janáky J (1989) 1,2,4-Triazoles, III: new 1,5-diaryl-3-(substituted amino)-1H-1,2,4-triazoles as anti-inflammatory agents. Arch Pharm 322:583
Meng J, Kung PP (2009) Rapid, microwave-assisted synthesis of N1-substituted 3-amino-1,2,4-triazoles. Tetrahedron Lett 50:1667–1670
Bogolyubsky AV, Savych O, Zhemera AV, Pipko SE, Grishchenko AV, Konovets AI, Vybornyi M (2018) Facile one-pot parallel synthesis of 3-amino-1,2,4-triazoles. ACS Comb Sci 20:461–466
Rohand T, Mkpenie VN, El Haddad M, Markó IE (2019) A novel Iron-catalyzed one-pot synthesis of 3-amino-1,2,4-triazoles. J Heterocycl Chem 56:690–695
Murlykina MV, Morozova AD, Zviagin IM, Sakhno YI, Desenko SM, Chebanov VA (2018) Aminoazole-based diversity-oriented synthesis of heterocycles. Front Chem 6:527
Sedash YV, Gorobets NY, Chebanov VA, Konovalova IS, Shishkin OV, Desenko SM (2012) Dotting the i’s in three-component Biginelli-like condensations using 3-amino-1,2,4-triazole as a 1,3-binucleophile. RSC Adv 2:6719–6728
Chebanov VA, Sakhno YI, Desenko SM, Shishkina SV, Musatov VI, Shishkin OV, Knyazeva IV (2005) Three-component procedure for the synthesis of 5-aryl-5,8-dihydroazolo[1,5-a]pyrimidine-7-carboxylic acids. Synthesis 2005:2597–2601
Parchinsky VZ, Koleda VV, Shuvalova O, Kravchenko DV, Krasavin M (2006) Air-oxidized products of multi-component reactions between 3-amino-1,2,4-triazole, aromatic aldehydes and isonitriles. Tetrahedron lett 47:6891–6894
Sakhno YI, Desenko SM, Shishkina SV, Shishkin OV, Sysoyev DO, Groth U, Chebanov VA (2008) Multicomponent cyclocondensation reactions of aminoazoles, arylpyruvic acids and aldehydes with controlled chemoselectivity. Tetrahedron 64:11041–11049
Chen Q, Jiang LL, Chen CN, Yang GF (2009) The first example of a regioselective Biginelli-like reaction based on 3-alkylthio-5-amino-1,2,4-triazole. J Heterocycl Chem 46:139–148
Lipson VV, Karnozhitskaya TM, Shishkina SV, Shishkin OV, Turov AV (2009) Reactions of 3-amino-1,2,4-triazoles with cinnamic aldehydes. Russ Chem Bull 58:1441–1444
Gorobets NY, Sedash YV, Ostras KS, Zaremba OV, Shishkina SV, Baumer VN, Van der Eycken EV (2010) Unexpected alternative direction of a Biginelli-like multicomponent reaction with 3-amino-1,2,4-triazole as the urea component. Tetrahedron lett 51:2095–2098
Rudenko RV, Komykhov SA, Musatov VI, Konovalova IS, Shishkin OV, Desenko SM (2011) Reactions of N-arylmaleimides with 3-amino-1,2,4-triazole and 2-aminobenzimidazole. J Heterocycl Chem 48:888–895
Gladkov ES, Gura KA, Sirko SM, Desenko SM, Groth U, Chebanov VA (2012) Features of the behavior of 4-amino-5-carboxamido-1,2,3-triazole in multicomponent heterocyclizations with carbonyl compounds. Beilstein J Org Chem 8:2100–2105
Muravyova EA, Desenko SM, Rudenko RV, Shishkina SV, Shishkin OV, Sen’ko YV, (2011) Switchable selectivity in multicomponent heterocyclizations of acetoacetamides, aldehydes, and 3-amino-1,2,4-triazoles/5-aminopyrazoles. Tetrahedron 67:9389–9400
Kolos NN, Kovalenko LU, Borovskoy VA (2011) Reactions of 3-aroylacrylates with α-aminoazoles. Chem Heterocycl Compd 47:983–988
Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Floyd DM (2011) Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem 54:3935–3949
Saito T, Obitsu T, Minamoto C, Sugiura T, Matsumura N, Ueno S, Toda M (2011) Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF1) receptor antagonists. Bioorg Med Chem 19:5955–5966
Petrova ON, Zamigajlo LL, Shishkina SV, Shishkin OV, Musatov VI, Borisov AV, Lipson VV (2013) A facile one-pot highly chemo-and regioselective synthesis of the novel heterocyclic system indolo[1,2-c]azolo[1,5-a]quinazoline-8,10-dione. Tetrahedron 69:11185–11190
Niu X, Yang B, Fang S, Li Y, Zhang Z, Jia J, Ma C (2014) An efficient one-pot synthesis of 1,2,4-triazoloquinoxalines. Tetrahedron 70:4657–4660
Farghaly A, T, S Shawali A, MH Abbas E, A Abdel-hafez N, (2015) A facile synthesis of new polyazaheterocycles via one-pot three-components condensation reaction and study of their reactions with nitrilimines. Curr Org Synth 12:95–101
Shaabani A, Seyyedhamzeh M, Ganji N, Hamidzad Sangachin M, Armaghan M (2015) One-pot four-component synthesis of highly substituted [1,2,4]triazolo[1,5-a] pyrimidines. Mol Divers 19:709–715
Karami B, Farahi M, Banaki Z (2015) A new protocol for catalyst-free regioselective synthesis of 5,9-dihydropyrimido[5,4-e][1,2,4]triazolo[1,5-a]pyrimidine-6,8(4H,7H)-diones. Synlett 26:741–744
Murlykina MV, Sakhno YI, Desenko SM, Shishkina SV, Shishkin OV, Sysoiev DO, Van der Eycken EV (2015) Study of the chemoselectivity of multicomponent heterocyclizations involving 3-amino-1,2,4-triazole and pyruvic acids as key reagents, and biological activity of the reaction products. Eur J Org Chem 2015:4481–4492
Aouali M, Mhalla D, Allouche F, El Kaim L, Tounsi S, Trigui M, Chabchoub F (2015) Synthesis, antimicrobial and antioxidant activities of imidazotriazoles and new multicomponent reaction toward 5-amino-1-phenyl[1,2,4]triazole derivatives. Med Chem Res 24:2732–2741
Karami B, Farahi M, Banaki Z (2015) A novel one-pot method for highly regioselective synthesis of triazoloapyrimidinedicarboxylates using silica sodium carbonate. Synlett 26:1804–1807
Moustafa AH, Amer AA (2017) A regioselective and convenient one-pot multicomponent synthesis of 9-amino-3,5-diaryl-4,9-dihydro-5H-[1,2,4]triazolo[5,1-c][1,2,4] triazepine-8-thiol. Synth Commun 47:1102–1109
Komykhov SA, Bondarenko AA, Musatov VI, Diachkov MV, Gorobets NY, Desenko SM (2017) (5S,7R)-5-Aryl-7-methyl-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-7-ols as products of three-component condensation. Chem Heterocycl Compd 53:378–380
Miszczyk P, Wieczorek D, Gałęzowska J, Dziuk B, Wietrzyk J, Chmielewska E (2017) Reaction of 3-amino-1,2,4-triazole with diethyl phosphite and triethyl orthoformate: acid-base properties and antiosteoporotic activities of the products. Molecules 22:254
Gladkov ES, Sirko SM, Musatov VI, Shishkina SV, Tkachenko IG, Komykhov SA, Desenko SM (2018) New spiro derivative of dihydro-1,2,3-triazolo[1,5-a]pyrimidine as a product of multicomponent reaction. Chem Heterocycl Compd 54:1139–1144
El-Saghier AM, Mohamed MA, Abdalla OA, Kadry AM (2018) Utility of amino acid coupled 1,2,4-triazoles in organic synthesis: synthesis of some new antileishmainal agents. Bull Chem Soc Ethiop 32:559–570
Sadek KU, Abdel-Hameed AM, Abdelnabi HA, Meleigy Y (2019) An efficient green synthesis of novel 1H-imidazo[1,2-a]imidazole-3-amine and imidazo[2,1-c][1,2,4]triazole-5-amine derivatives via Strecker reaction under controlled microwave heating. Green Process Synth 8:297–301
Safari F, Bayat M, Nasri S, Karami S (2020) Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a]pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process. Bioorg Med Chem Lett 30:127111
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nasri, S., Bayat, M. & Kochia, K. Strategies for synthesis of 1,2,4-triazole-containing scaffolds using 3-amino-1,2,4-triazole. Mol Divers 26, 717–739 (2022). https://doi.org/10.1007/s11030-021-10197-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-021-10197-4